Thyroid Storm

Definition

Thyroid storm (TS) is the most severe, life-threatening clinical expression of thyrotoxicosis: an acute syndrome of exaggerated thyroid-hormone effects with systemic decompensation, commonly involving the cardiovascular, thermoregulatory, gastrointestinal/hepatic, and central nervous systems. It is typically precipitated by an acute illness or other stressor, although the trigger may not always be immediately apparent. ^[7]A1c[11]D5 The defining clinical concept is not simply a high thyroid-hormone concentration, but thyrotoxicosis accompanied by decompensation of one or more organ systems. ^[4]C4[7]A1c

Thyrotoxicosis denotes excessive circulating thyroid-hormone action from any cause, whereas hyperthyroidism specifically refers to excessive synthesis and secretion of thyroid hormone by the thyroid gland. This distinction is relevant because TS may arise from endogenous hyperthyroidism, including Graves’ disease or toxic nodular disease, or from other causes of thyrotoxicosis. Graves’ disease is the most frequently reported underlying cause in several clinical series, but TS has also been reported with toxic multinodular goitre and other etiologies. ^{[1]B2b[7]A1c[11]D5[112]C}

Diagnostic axis and nomenclature

The thyroid axis is conventionally described using thyrotropin (TSH) and the circulating thyroid hormones free thyroxine (FT4) and free triiodothyronine (FT3). In primary thyroid overactivity, thyroid hormone excess is generally associated with suppressed TSH; however, the biochemical pattern must be interpreted with the clinical syndrome rather than used alone to establish TS. A rare alternative is central hyperthyroidism caused by a TSH-secreting pituitary adenoma, in which TSH may be inappropriately normal or elevated despite increased thyroid hormones. ^[1]B2b[9]C4

For clinical writing, the following terms should be kept distinct: thyrotoxicosis describes the biochemical and physiological state; hyperthyroidism identifies thyroid-driven hormone production; thyroid storm identifies thyrotoxicosis with acute multisystem decompensation; and compensated thyrotoxicosis describes hospitalized thyrotoxic patients without the clinical features required for TS. ^{[1]B2b[4]C4[7]A1c}

A thyroid storm may be described as “definite,” “probable,” or “suspected” in narrative documentation, but the principal validated Japanese classification uses TS1 and TS2. The Japanese criteria were developed from clinical cases and nationwide surveys and were subsequently incorporated into management guidance. ^{[4]C4[5]D5[7]A1c}

Japanese classification: TS1 and TS2

The Japanese Thyroid Association criteria require documented thyrotoxicosis as a prerequisite and classify illness according to combinations of central nervous system (CNS) manifestations, fever, tachycardia, congestive heart failure (CHF), and gastrointestinal/hepatic disturbance. ^[4]C4[7]A1c

TS1 (definite thyroid storm) is established by thyrotoxicosis plus either a CNS manifestation together with at least one additional systemic feature, or at least three systemic features among fever, tachycardia, CHF, and gastrointestinal/hepatic manifestations. ^[4]C4[7]A1c

TS2 (impending or less severe thyroid storm) is established by thyrotoxicosis plus either a CNS manifestation with one systemic feature, or at least two systemic features among fever, tachycardia, CHF, and gastrointestinal/hepatic manifestations. ^[4]C4[7]A1c When the TS2 pattern is present, the absence of CNS manifestations does not exclude clinically important storm physiology, and prompt treatment is required because progression can be rapid. ^[7]A1c[11]D5

The CNS domain includes agitation, delirium, mental-status alteration, lethargy, or coma. The cardiovascular domain includes tachycardia and CHF; the latter may range from pulmonary congestion to severe acute heart failure. Gastrointestinal/hepatic involvement includes nausea, vomiting, diarrhea, abdominal symptoms, or hepatic dysfunction. ^{[4]C4[7]A1c[11]D5} These domains are syndromic rather than disease-specific, so alternative diagnoses and precipitating illnesses must be assessed concurrently. ^[7]A1c[11]D5

Relationship to the Burch–Wartofsky framework

The Burch–Wartofsky Point Scale (BWPS) is an alternative clinical scoring system that integrates temperature, tachycardia, CNS effects, gastrointestinal/hepatic dysfunction, heart failure, and precipitating events. A score of ≥45 points is commonly interpreted as strongly supportive of TS, whereas lower scores may indicate an intermediate or impending presentation; the score should support, not replace, clinical judgment. ^{[1]B2b[2]D5[11]D5} Studies comparing BWPS with the Japanese criteria demonstrate that different classification systems may identify overlapping but nonidentical patient populations. ^[1]B2b

Practical nomenclature

A complete diagnostic label should specify: (1) the underlying cause of thyrotoxicosis; (2) whether the presentation meets TS1 or TS2; (3) the dominant decompensated organ systems; and (4) the precipitating event, if identified. For example, “Graves-related TS1 with acute heart failure and CNS dysfunction precipitated by infection” is more informative than “severe hyperthyroidism.” This terminology reflects the evidence that acute heart failure, multiorgan failure, and cardiovascular complications are major determinants of outcome. ^{[7]A1c[110][12]B2b}

Because thyroid-hormone concentrations do not reliably quantify the severity of systemic decompensation, a patient should not be excluded from TS classification solely because hormone levels are not markedly higher than those in non-storm thyrotoxicosis. Diagnosis remains clinical and requires urgent evaluation for alternative causes of fever, tachycardia, altered mental status, heart failure, and gastrointestinal or hepatic dysfunction. ^{[1]B2b[4]C4[7]A1c[11]D5}

Physiological axis and biochemical definition

The hypothalamic–pituitary–thyroid axis is biochemically characterized by pituitary thyrotropin (TSH) stimulation of thyroidal hormone synthesis and release, with circulating free thyroxine (FT4) and free triiodothyronine (FT3) providing the principal biochemical indicators of thyroid status. In overt thyrotoxicosis, TSH is typically suppressed while FT4 and/or FT3 are elevated; confirmation should be followed by etiological classification. ^[20]D5 Thyroid storm is not defined by a unique hormone concentration or by biochemical severity alone. It represents decompensation of a previously compensated thyrotoxic state, in which metabolic, thermoregulatory, cardiovascular, respiratory, gastrointestinal, and neuropsychiatric compensatory mechanisms are overwhelmed. ^[27]D5[18]D5

FT4 is the principal circulating prohormone, whereas FT3 is the more biologically active hormone at tissue receptors; peripheral conversion between thyroid hormones is therefore central to the biochemical phenotype. Amiodarone can disrupt this physiology through iodine loading and effects on thyroid hormone metabolism, producing either hypothyroidism or thyrotoxicosis and complicating interpretation of thyroid tests. ^[21]D5 Amiodarone-associated thyrotoxicosis is recognized among drug-related causes of hyperthyroidism, alongside tyrosine-kinase inhibitors and immune checkpoint inhibitors. ^[20]D5

Mechanisms of storm physiology

The transition from thyrotoxicosis to storm is usually precipitated by an acute stressor rather than explained by hormone concentrations alone. The resulting syndrome combines excessive thyroid-hormone action with adrenergic and systemic stress responses, producing hyperthermia, tachycardia or tachyarrhythmia, altered mental status, gastrointestinal or hepatic dysfunction, and potentially cardiovascular collapse. ^[27]D5[30]C4 Cardiopulmonary failure is reported as the most common cause of death, and cardiopulmonary failure may be the initial presentation of previously unrecognized Graves disease. ^[30]C4

Thyroid hormone excess increases cardiovascular susceptibility to tachyarrhythmias and myocardial dysfunction. Atrial fibrillation is a common complication of hyperthyroidism, while severe crisis may cause malignant ventricular arrhythmias, cardiac arrest, cardiogenic shock, or stress-related myocardial injury. ^{[18]D5[20]D5[23]C4} A reported thyroid-storm case demonstrated ventricular fibrillation with increased FT3 and FT4, suppressed TSH, and positive TSH-receptor antibodies. ^[23]C4 Another report described thyrotoxicosis-associated Takotsubo syndrome with apical thrombosis, marked ST-segment elevation, and increased troponin T and B-type natriuretic peptide; the authors implicated catecholamine excess while noting that the mechanism remains incompletely understood. ^[22]C4

Gastrointestinal and metabolic manifestations reflect multisystem decompensation. Nausea, vomiting, diarrhea, abdominal symptoms, and, rarely, persistent hiccups have been reported in severe endocrine and metabolic crisis; unusual gastrointestinal manifestations can delay recognition and worsen prognosis. ^[24]C4 Thyroid storm may also present with severe weakness or neurological dysfunction, including encephalopathy and seizures in complicated cases. ^[28]C4

Etiological signatures

Graves disease is the leading cause of hyperthyroidism and is mediated by stimulatory antibodies against the TSH receptor. TSH-receptor antibodies (TRAb), thyroid peroxidase antibodies, ultrasonography, and scintigraphy help establish the cause of biochemical thyrotoxicosis. ^[20]D5 In pregnancy, maternal TRAb can cross the placenta and predict neonatal thyroid dysfunction; in a prospective cohort using a third-generation assay, maternal TRAb concentrations above 19.06 IU/L (10.9 times the upper limit of normal) were associated with adverse pregnancy outcomes. ^[114]

Thyroid storm can occur with Graves disease even when the biochemical profile is not sufficient by itself to distinguish storm from uncomplicated thyrotoxicosis. A retrospective study specifically compared clinical, biochemical, hematological, endocrinological, and immunological characteristics of Graves patients with and without storm using Japanese diagnostic guidance, underscoring the need for integrated clinical assessment rather than reliance on a single laboratory value. ^[111]

Other etiologies have distinct biochemical patterns. Thyroiditis and drug-associated disease are recognized causes of thyrotoxicosis, while immune checkpoint inhibitor–associated thyroid dysfunction may progress from subclinical abnormalities to thyroid storm through immune-tolerance breakdown, autoreactive T-cell activity, cytokine signaling, and epitope spreading. Anti-PD-1/PD-L1 therapies are associated particularly with destructive thyroiditis, anti-CTLA-4 therapy may affect thyroid function indirectly through hypophysitis, and combination treatment may accelerate toxicity. ^[25]D5 Ectopic hormone production should be considered when thyroid antibodies and thyroid scintigraphy are negative: in struma ovarii, pelvic iodine uptake and an ovarian thyroid-tissue tumor identified the source of excess thyroid hormone. ^[31]C4

Circulating hormone burden and removal

Because thyroid hormones are protein-bound and circulate in plasma, therapeutic plasma exchange (TPE) can rapidly reduce circulating hormone concentrations and may rescue selected patients with life-threatening, refractory, or treatment-limited storm. TPE is classified by the American Society for Apheresis as a category II indication, but the recommendation remains Grade 2C, reflecting reliance mainly on retrospective series and case reports rather than prospective randomized trials. ^[29]C4 Double-filtration plasmapheresis has also been reported in storm with encephalopathy and leukopenia, when antithyroid drugs were contraindicated; after three sessions, TRAb and thyroid hormone concentrations decreased. ^[28]C4

Clinical interpretation

The biochemical signature of storm is therefore usually suppressed TSH with increased FT4 and/or FT3, but diagnosis requires evidence of acute multisystem decompensation, not a numerical hormone threshold. ^[20]D5[27]D5 Normalization of laboratory values may lag behind clinical deterioration or recovery, and treatment decisions must integrate temperature, cardiovascular status, neurological findings, gastrointestinal or hepatic involvement, precipitating events, and the underlying cause. ^{[18]D5[27]D5[30]C4}

Epidemiology

Thyroid storm (thyrotoxic crisis) is a rare, life-threatening manifestation of severe thyrotoxicosis characterized by systemic decompensation and risk of multiorgan failure.^[36]D5 Published estimates of incidence vary according to case definition and ascertainment method; one emergency-medicine report estimates 0.61–0.76 cases per 100,000 people.^[125]C Population-based studies have used administrative or claims databases to examine incidence, mortality, hospitalization, length of stay, costs, and temporal trends, including a German analysis covering 2007–2017 and United States national inpatient analyses covering 2004–2013 and 2016–2020.^{[6]B2c[32]B2b[3]B2c} These studies reflect hospitalized or coded disease and therefore may not capture undiagnosed, prehospital, or differently classified cases.^{[6]B2c[32]B2b[3]B2c}

Mortality remains substantial despite modern treatment. Reviews commonly cite mortality around 10%, while case-based emergency literature reports mortality of up to 30% without immediate treatment.^{[33]B2b[11]D5[125]C} Differences probably reflect variation in diagnostic criteria, illness severity, comorbidity, treatment delay, and study setting; the Japanese prospective multicenter registry included 110 patients with new-onset thyroid storm and evaluated outcomes at 30 and 180 days, while noting that previously reported mortality exceeded 10%.^[33]B2b A 2026 Thai retrospective cohort specifically evaluated predictors of 30-day all-cause mortality and developed an internally bootstrapped prognostic score, underscoring that prognosis is heterogeneous rather than determined by hormone concentrations alone.^[68]B2b

Pediatric thyroid storm is uncommon, and the evidence base is limited largely to case reports and case series; pediatric practice is therefore substantially extrapolated from adult data.^[41]C4 In an Indian inpatient series of 35 patients meeting a Burch–Wartofsky score of ≥45, 71.4% were women, the mean age was 44.9 ± 10.2 years, and 43% had no previous history of thyrotoxicosis.^[112]C

Etiology

Thyroid storm usually develops in patients with untreated or inadequately controlled hyperthyroidism, most often Graves disease.^[36]D5 In general hyperthyroidism, Graves hyperthyroidism accounts for approximately 70% of cases and toxic nodular goiter for approximately 16%; subacute granulomatous thyroiditis accounts for about 3%, and drug-related disease for about 9%.^[20]D5 Consistent with this etiologic pattern, Graves disease was the underlying cause in 71.4% of the Indian thyroid-storm series, followed by toxic multinodular goiter in 14.3%.^[112]C Other reported causes include toxic nodular disease, thyroiditis, iodine-induced hyperthyroidism, and medication-related thyroid dysfunction.^[20]D5[39]D5

Iodine exposure can precipitate hyperthyroidism when normal autoregulation fails, particularly in historically iodine-deficient regions with a higher prevalence of autonomous thyroid nodules; iodine-induced hyperthyroidism can also occur in regions with otherwise adequate iodine intake.^[39]D5 Relevant exposures may include iodine-containing medicines, contrast, or other iodine sources, although the specific source must be established clinically.^[39]D5 Pregnancy-related thyrotoxicosis is most commonly due to gestational transient thyrotoxicosis, although Graves disease and, less often, toxic nodular disease occur; untreated or inadequately controlled overt maternal hyperthyroidism is associated with thyroid storm.^[122]D

Autoimmune thyroid disease may rarely follow SARS-CoV-2 infection. A systematic review identified 20 reported cases—14 Graves disease, five Hashimoto thyroiditis cases causing hypothyroidism, and one postpartum thyroiditis case—but found no prevalence study, so COVID-19-associated autoimmune thyroiditis should not be interpreted as a quantified population risk for thyroid storm.^[43]C4 During COVID-19, uncontrolled thyrotoxicosis may worsen complications of SARS-CoV-2 infection, and infection-related symptoms may be confused with antithyroid-drug adverse effects or thyroid decompensation.^[37]D5

Precipitating factors and risk factors

Common precipitants include infection, surgery, trauma, abrupt discontinuation of antithyroid medication, severe emotional or physical stress, and iodine exposure.^[36]D5 Acute trauma to the thyroid, severe emotional stress, and infection, surgery, or trauma more broadly have also been described as triggers.^[125]C Rapid-sequence intubation has been reported as an immediate clinical context for storm, although the underlying mechanism may involve physiologic stress in a patient with previously unrecognized hyperthyroidism.^[125]C

The principal modifiable risk is untreated or poorly controlled hyperthyroidism, including interruption of antithyroid therapy.^[36]D5 Socioeconomic disadvantage may increase the likelihood of complicated thyrotoxicosis requiring hospitalization: a West Texas safety-net hospital study evaluated whether unfavorable socioeconomic conditions contributed to high admission rates and poor outcomes among adults with thyrotoxicosis.^[34]C4 In that setting, healthcare access and social circumstances were considered clinically relevant contributors, although the findings are regional and do not establish universal causality.^[34]C4

Risk of severe cardiovascular decompensation is particularly important. In a 56-patient retrospective study, cardiogenic shock was associated with higher body mass index, previous heart failure, elevated pro-B-type natriuretic peptide, interstitial edema on chest radiography, and a higher Burch–Wartofsky score; heart failure history had an odds ratio of 8.33 and radiographic interstitial edema an odds ratio of 3.33.^[126] Cardiogenic-shock cases had longer hospitalization—16.5 versus 4 days—and markedly higher in-hospital mortality, with an odds ratio of 24.5.^[126] Thyrotoxicosis may also precipitate acute coronary syndromes; a 2025 review identified 35 reported cases, with a mean age in the fourth decade and female predominance of 57%.^[38]B2a

Genetic susceptibility may influence the development or phenotype of hyperthyroidism. A Taiwanese electronic-medical-record genome-wide association study involving 35,009 individuals identified 2,767 patients with hyperthyroidism and reported 44 novel genomic risk markers across 10 loci.^[35]B3b These findings concern hyperthyroidism rather than thyroid storm specifically and should therefore be regarded as background susceptibility evidence, not a validated storm-prediction tool.^[35]B3b

Overview

Thyroid storm is the extreme, decompensated end of thyrotoxicosis, occurring when metabolic, thermoregulatory, cardiovascular, and neurologic compensatory mechanisms are overwhelmed. ^[27]D5 It is a rare endocrine emergency with substantial morbidity and mortality; published reports describe mortality of approximately 8%–25%, while one retrospective series cites an overall mortality of about 10%. ^[48]C4[112]C The diagnosis is clinical: there is no single laboratory value that establishes thyroid storm, and markedly abnormal thyroid hormone concentrations may overlap with uncomplicated thyrotoxicosis. ^[18]D5[27]D5

Patients may have previously recognized hyperthyroidism, but undiagnosed disease is common in acute presentations. In an Indian retrospective series of 35 patients meeting a Burch–Wartofsky score (BWS) of ≥45, 43% had no prior history of thyrotoxicosis. ^[112]C Graves disease was the leading etiology (71.4%), followed by toxic multinodular goiter (14.3%). ^[112]C Thyroid storm can also arise from less typical causes, including thyrotropin-secreting pituitary adenoma, which produces hyperthyroidism with an inappropriately normal or elevated thyroid-stimulating hormone level and may create diagnostic uncertainty. ^[9]C4

Core clinical features

The presentation usually combines hyperthermia, marked tachycardia or tachyarrhythmia, neuropsychiatric disturbance, and gastrointestinal or hepatic dysfunction. ^[27]D5[46]D5 Hyperthermia may be prominent, while neurologic manifestations range from anxiety, agitation, and delirium to altered mental status, obtundation, or coma. ^{[18]D5[27]D5[46]D5} Gastrointestinal symptoms may include nausea, vomiting, abdominal discomfort, or diarrhea; severe cases may develop hepatic dysfunction or jaundice. ^[18]D5[46]D5

Cardiovascular involvement is often dominant and may determine immediate prognosis. Patients can develop persistent sinus tachycardia, atrial fibrillation, other tachyarrhythmias, hypertension early in the course, hypotension, acute heart failure, pulmonary edema, cardiogenic shock, or cardiovascular collapse. ^{[18]D5[27]D5[46]D5} Atrial fibrillation is described as the most common cardiovascular manifestation of severe hyperthyroidism. ^[18]D5 Cardiac function requires particular attention because patients may deteriorate into collapse during the clinical course or during treatment. ^[46]D5

The cardiovascular spectrum may include acute coronary syndromes. Uncontrolled Graves disease has been reported with ST-segment-elevation myocardial infarction caused by spontaneous coronary artery dissection despite non-obstructive coronary anatomy, extending the recognized cardiovascular complications beyond coronary vasospasm. ^[55]C4 Severe or treatment-resistant storm may progress to heart failure requiring intensive care and, in exceptional cases, extracorporeal membrane oxygenation. ^[116]C In a Taiwanese ICU series of storm patients receiving ECMO, ICU mortality was the principal outcome, underscoring the severity of this presentation. ^[116]C

Precipitating contexts

Storm generally develops when a precipitating event converts compensated thyrotoxicosis into multisystem decompensation. ^[27]D5 Common clinical contexts include infection, surgery, withdrawal or irregular use of antithyroid medication, and other major physiologic stressors. ^[27]D5[48]C4 Perioperative storm may occur during or after non-thyroid surgery when thyroid status was not recognized preoperatively. ^[47]C4[48]C4 Reported cases include refractory intraoperative tachycardia during knee arthroplasty in a patient whose hyperthyroidism was identified only after surgery, and storm during the recovery phase after orthopedic surgery in a patient with long-standing poorly controlled disease and irregular medication adherence. ^[47]C4[48]C4

Local epinephrine administration can also precipitate an acute cardiovascular crisis in previously unrecognized hyperthyroidism. A reported 29-year-old woman developed cardiovascular crisis after submucosal epinephrine-saline injection during vaginal tightening surgery, a setting in which highly vascular vaginal mucosa may permit rapid systemic epinephrine absorption and amplify tachycardia and hypertension. ^[57]C4 Non-thyroid procedures may therefore expose occult hyperthyroidism because thyroid function assessment is often not performed before surgery. ^[47]C4[57]C4

Important mimics and associated findings

Fever, tachycardia, respiratory distress, heart failure, and altered mental status are not specific to thyroid storm. Acute rheumatic fever was reported to mimic storm in a 16-year-old with hyperthyroidism, fever, orthopnea, productive cough, palpitations, and tachypnea; an initial storm diagnosis was made and treatment begun before the alternative diagnosis was recognized. ^[117]C Storm should therefore be reassessed when the clinical trajectory, cardiac findings, or inflammatory features are discordant with thyrotoxicosis. ^[117]C

Other associated presentations may reflect either thyrotoxicosis or its treatment. Thyrotoxic periodic paralysis causes transient muscle weakness through hypokalemia from intracellular potassium shifting and requires cautious potassium replacement. ^[18]D5 Methimazole-associated bilateral parotid enlargement has been described after a recent storm; imaging showed fatty replacement without calculi, and symptoms improved after treatment adjustment. ^[56]C4 Concurrent primary hyperparathyroidism has also been reported in a patient with Graves-related primary hyperthyroidism, illustrating that coexisting endocrine disease may complicate the presentation and perioperative assessment. ^[118]C

Severe and fatal presentations

The most advanced presentations include multiorgan failure, refractory heart failure, shock, respiratory failure, and death. ^{[27]D5[46]D5[59]C4[116]C} A case of treatment-resistant storm with concurrent heart failure required consideration of plasma exchange and definitive thyroid treatment after inadequate response to conventional therapy. ^[59]C4 Another report described a young adolescent with palpitations, fatigue, headache, and neck swelling who had tachycardia and elevated thyroid hormone levels, was discharged after beta-blocker treatment, and subsequently died; forensic evaluation attributed death to multiorgan failure related to thyroid disease. ^[58]C4 These reports emphasize that apparently limited initial symptoms can precede rapid deterioration and that clinical severity, rather than hormone concentration alone, should guide recognition of storm. ^[46]D5[58]C4

The transition from severe thyrotoxicosis to thyroid storm is a clinical diagnosis, not a biochemical one ^[36]D5. Although the preceding section detailed the protean manifestations, it is the constellation of hyperthermia, tachycardia, and central nervous system dysfunction that should trigger immediate consideration of this diagnosis. No single laboratory threshold defines the transition; the decision to treat aggressively must be made at the bedside before confirmatory tests return.

History and Physical

Key features that should raise suspicion include:

• Central nervous system dysfunction - agitation, confusion, delirium, or coma (the single feature most reliably distinguishing storm from compensated thyrotoxicosis) ^[1]B2b
• Hyperthermia - fever >100.4°F (38°C) ^[1]B2b
• Tachycardia - heart rate >100 beats/min, often >140 beats/min, with atrial fibrillation in up to 50% of cases ^[1]B2b
• Gastrointestinal symptoms - vomiting, diarrhea, abdominal pain, jaundice
• Presence of a precipitating event - infection, surgery, trauma, amiodarone exposure, discontinuation of antithyroid drugs, or recent iodine load ^[36]D5
• Cardiovascular compromise - heart failure, hypotension, pulmonary edema; Takotsubo cardiomyopathy may be a presenting manifestation ^[50]C4
• Profuse sweating and heat intolerance

Diagnostic delay is common. In a 12-year cohort study, median time from symptom onset to diagnosis was 5 days (interquartile range 3.5-7). Older age (1.08 days per 10-year increase; P <.001), initial onset of hyperthyroidism (4.10 days; P <.001), and admission to a non-emergency department (2.76 days; P =.004) were independently associated with longer delays ^[67]B2b. Delayed recognition was linked to increased need for intensive care and organ support ^[67]B2b.

Gold Standard: Clinical Diagnosis with Scoring Systems

No single test confirms thyroid storm. The Burch-Wartofsky Point Scale (BWPS) and the Japanese Thyroid Association (JTA) 2012 criteria are the two most widely used diagnostic tools ^[2]D5. Both are clinical scoring systems designed to standardize the diagnosis and guide treatment urgency.

The BWPS assigns points for:

Higher scores indicate greater probability of storm. A score of 45 or higher is considered highly suggestive of definite storm, 25-44 indicates impending storm, and <25 makes storm unlikely ^[1]B2b. The JTA criteria use a similar approach but define major and minor manifestations with a required combination for diagnosis ^[2]D5.

Important caveat: The BWPS may overdiagnose thyroid storm in patients who lack CNS dysfunction. In the original validation cohort, altered mentation was the only feature that distinguished clinically diagnosed storm from patients who met BWPS criteria but were not treated as storm ^[1]B2b. Therefore, clinical judgment remains paramount; a patient with fever, tachycardia, and a precipitant but a clear sensorium may have severe thyrotoxicosis without storm.

Laboratory Studies

Once thyroid storm is suspected, the following tests should be obtained urgently:

• Thyroid-stimulating hormone (TSH) - suppressed (<0.01 mIU/L) ^[20]D5
• Free thyroxine (FT4) and free triiodothyronine (FT3) - both elevated, often markedly ^[20]D5. The degree of elevation does not correlate with storm severity; patients with minimally elevated hormones can be in storm, and those with very high levels may remain compensated ^[36]D5.
• Complete blood count - to identify infection and assess for agranulocytosis (especially if future antithyroid drug use is planned)
• Electrolytes, liver enzymes, and bilirubin - hepatic dysfunction is common and may be severe ^[61]C4
• Lactate and coagulation profile - evidence of lactic acidosis or disseminated intravascular coagulation indicates multiorgan failure ^[61]C4
• B-type natriuretic peptide (BNP) or NT-proBNP - if heart failure is suspected
• Thyroid peroxidase antibodies, TSH-receptor antibodies - to confirm autoimmune etiology (Graves’ disease) ^[20]D5

Pitfall: Thyroid function tests should not delay treatment. If the clinical picture is convincing, initiate therapy while awaiting results.

Imaging

Imaging is not required for the diagnosis of thyroid storm itself but is essential to identify the underlying cause once the patient is stabilized:

• Thyroid ultrasound - to assess gland size, echogenicity, and nodularity; Graves’ disease shows diffuse hypoechogenicity with increased vascularity ^[20]D5
• Scintigraphy - radioactive iodine uptake scan (e.g., 24-hour uptake) helps distinguish Graves’ disease (high uptake) from destructive thyroiditis (low uptake) ^[20]D5. However, iodine administration is contraindicated in the acute phase if storm is suspected; scintigraphy is reserved for after resolution.
• Cardiac echocardiography - to evaluate left ventricular function, wall motion abnormalities, and valvular disease; Takotsubo cardiomyopathy may be present ^[50]C4

In atypical presentations (e.g., inappropriately normal or high TSH with elevated FT4/FT3), consider a TSH-secreting pituitary adenoma and proceed with pituitary MRI and dynamic testing ^[9]C4.

Diagnostic Algorithm

Step 1: At the bedside, apply the BWPS or JTA criteria. If the score is high or Criterion A is met (e.g., altered mentation with fever >38°C and tachycardia >130 bpm), diagnose thyroid storm and proceed to treatment immediately. Do not wait for lab results.

Step 2: Simultaneously obtain blood for thyroid function tests and other labs. The degree of TSH suppression and FT4/FT3 elevation supports the diagnosis but does not override the clinical assessment.

Step 3: Search for a precipitating event (infection, medication nonadherence, iodine exposure, surgery) and begin treatment of the underlying cause.

Step 4: If the clinical picture is equivocal (e.g., fever and tachycardia from sepsis alone), treat the suspected precipitant first and re-evaluate. If the diagnosis remains uncertain but storm is still a possibility, it is safer to treat for storm than to miss it, given the high mortality of untreated disease ^[36]D5.

Step 5: Once the patient is stabilized, complete the etiologic workup with thyroid ultrasound, antibody testing, and, if indicated, scintigraphy or pituitary imaging.

Pearl: The single most reliable feature distinguishing thyroid storm from compensated thyrotoxicosis is central nervous system dysfunction (altered mentation) ^[1]B2b.

Clinical spectrum and definition

Thyroid storm (TS) is the most severe clinical expression of thyrotoxicosis: a life-threatening, multisystem decompensation rather than a diagnosis defined by thyroid-hormone concentration alone.^[20]D5[46]D5 Patients may have fever, marked tachycardia, agitation or altered mental status, gastrointestinal or hepatic dysfunction, cardiovascular failure, and other organ complications.^{[1]B2b[20]D5[46]D5} Early manifestations can be nonspecific, and neurological presentations may dominate or obscure the endocrine cause.^[120]D Psychiatric symptoms, including agitation, psychosis, hypomania, or hallucinations, can occur in Graves’ disease and may complicate recognition of severe thyrotoxicosis.^[119]C

There is no universally accepted biochemical threshold that separates uncomplicated thyrotoxicosis from TS; clinical instability and organ dysfunction are central to severity assessment.^{[1]B2b[2]D5[20]D5} Free thyroxine and free triiodothyronine concentrations confirm thyrotoxicosis but do not, by themselves, establish the severity of the systemic crisis.^[20]D5[46]D5 Conversely, symptom severity may not correlate directly with a single biochemical marker: in hyperthyroidism associated with molar pregnancy, markedly elevated β-human chorionic gonadotropin may produce severe thyrotoxicosis, but β-hCG concentration does not necessarily reflect clinical severity.^[101]C4

Diagnostic staging systems

Two bedside approaches are most commonly used. The Burch–Wartofsky Point Scale (BWPS) assigns points for thermoregulatory dysfunction, tachycardia, gastrointestinal or hepatic manifestations, central nervous system disturbance, heart failure, atrial fibrillation, and a precipitating event.^[1]B2b[2]D5 A score of ≥45 points is generally considered highly suggestive of TS, 25–44 points indicates impending or probable storm, and <25 points makes TS less likely; these thresholds support clinical judgment and are not substitutes for evaluation of alternative causes of systemic deterioration.^[1]B2b[2]D5

The Japanese Thyroid Association/Japanese Endocrine Society criteria classify TS as TS1 or TS2 according to central nervous system involvement and combinations of fever, tachycardia, congestive heart failure, and gastrointestinal or hepatic manifestations.^[2]D5[33]B2b TS1 represents the more definitive or severe category, whereas TS2 identifies a clinically compatible but less extensive presentation.^[2]D5[33]B2b In comparative hospital data, BWPS and Japanese criteria did not classify every patient identically, demonstrating that diagnostic staging can vary according to the instrument used.^[1]B2b

These systems should be interpreted as clinical syndromic tools. A patient with severe thyrotoxicosis and evolving shock, heart failure, delirium, or hepatic dysfunction may require intensive-care-level management even when a score is borderline, while fever or tachycardia from infection, medication, withdrawal, or another critical illness can inflate a score.^{[1]B2b[2]D5[46]D5}

Organ-based severity assessment

Cardiovascular involvement is a major determinant of clinical severity. Reported complications include atrial fibrillation and other arrhythmias, acute heart failure, ischemia, cardiogenic shock, and cardiac arrest.^[70]C4[110] In a retrospective series of TS with acute decompensated heart failure, elevated brain natriuretic peptide together with left-ventricular dilatation identified patients who might require temporary percutaneous mechanical circulatory support in addition to beta-blockade to prevent or manage cardiogenic shock.^[70]C4 Before treatment, cardiac function should therefore be assessed carefully because abrupt cardiovascular collapse can occur in severely thyrotoxic patients.^[46]D5

Neurological dysfunction ranges from anxiety, agitation, and delirium to seizures, coma, and psychosis.^[119]C[120]D Gastrointestinal or hepatic involvement—particularly persistent vomiting, diarrhea, abdominal symptoms, or hepatic dysfunction—indicates systemic decompensation; rare gastrointestinal manifestations such as intractable hiccups have also been reported in severe endocrine crisis.^[24]C4 Fever and tachycardia are important severity markers, but absence of high fever does not exclude TS, particularly in older adults or patients with atypical presentations.^[1]B2b[2]D5

Prognostic risk stratification

TS remains associated with substantial mortality. Contemporary registry and administrative studies continue to report mortality exceeding 10% in severe or hospitalized disease, although estimates vary with case definition, population, and treatment setting.^{[15]B2b[33]B2b[6]B2c} In a prospective Japanese multicenter registry of 110 new-onset cases, the median APACHE II score was 13, compared with 10 in an earlier nationwide epidemiological study, supporting the use of general critical-illness severity measures alongside TS-specific criteria.^[33]B2b The same registry found clinically meaningful relationships between outcome and factors including lower body mass index and post-resuscitation status.^[2]D5

A 2026 retrospective cohort developed and internally bootstrap-validated a practical prognostic score for 30-day all-cause mortality, using multivariable clinical and biochemical predictors rather than diagnostic criteria alone.^[68]B2b Because this score derives from a single tertiary-care cohort and requires external validation, it should be viewed as adjunctive rather than definitive risk classification.^[68]B2b Delayed diagnosis is also clinically important: a 12-year cohort specifically evaluated determinants of diagnostic delay and its association with severe outcomes, emphasizing that diagnostic timing is itself a modifiable risk domain.^[67]B2b

Population-level studies show that TS carries greater resource use and worse outcomes than thyrotoxicosis without storm.^[3]B2c Cardiovascular events are frequent in hospitalized TS and should be actively screened for because they materially influence prognosis.^[110] Men hospitalized with hyperthyroidism may have greater comorbidity burden and worse outcomes than women in national data, although these findings concern hospitalized hyperthyroidism broadly and should not be treated as a TS-specific staging rule.^[127]D

Special settings and risk modifiers

Children and adolescents can develop TS, but the pediatric evidence base is dominated by case reports and case series; adult diagnostic and severity frameworks are therefore commonly extrapolated, with caution.^[41]C4 Surgery is a potential precipitant, yet a systematic review found insufficient evidence to quantify perioperative TS risk reliably across preoperative strategies, including thionamides, iodine, beta-blockers, and combinations; restoration of euthyroidism was inconsistently reported.^[8]A1a Accordingly, perioperative risk should be individualized according to biochemical control, cardiovascular reserve, precipitating disease, and planned surgical stress rather than assigned from a validated universal score.^[8]A1a

In practice, the highest-risk phenotype is TS with central nervous system dysfunction plus cardiovascular compromise, hyperthermia, gastrointestinal/hepatic involvement, shock, or multiple failing organs.^{[1]B2b[2]D5[33]B2b[70]C4} Such patients require immediate resuscitation, intensive monitoring, treatment of the precipitant, and prompt multimodal TS therapy; diagnostic scores should never delay stabilization.^{[15]B2b[33]B2b[46]D5}

Recognition and immediate priorities

Thyroid storm is a rare, life-threatening hypermetabolic syndrome caused by severe thyrotoxicosis and multisystem decompensation; diagnosis is clinical rather than biochemical, so treatment should not await a particular thyroid-hormone concentration. ^[36]D5 Typical manifestations include hyperthermia, tachyarrhythmia, cardiac or respiratory failure, hepatic dysfunction, agitation, delirium, confusion, vomiting, diarrhea, and profuse sweating. ^[36]D5 Initial management requires resuscitation, assessment for organ failure, continuous cardiovascular and respiratory monitoring, and prompt investigation and treatment of the precipitating cause. ^[46]D5 Common precipitants include infection, surgery, trauma, abrupt antithyroid-drug withdrawal, severe physical or emotional stress, and iodine exposure. ^[36]D5

Diagnostic delay is clinically important because delayed recognition is associated with severe outcomes; factors examined in a 12-year cohort included age, first versus recurrent storm, admitting department, presenting symptoms, and cardiac-rhythm abnormalities. ^[67]B2b Consider alternative diagnoses when the presentation is atypical or the response to thyroid-storm therapy is poor: acute rheumatic fever can mimic thyroid storm in adolescents with fever, respiratory symptoms, palpitations, and tachypnea. ^[117]C In that reported case, thyroid-storm-directed therapy and anti-infective treatment were initially given before the alternative diagnosis was recognized. ^[117]C

Cardiovascular and supportive care

Cardiac function should be assessed before and during treatment because patients with thyroid storm may deteriorate to cardiac collapse. ^[46]D5 Rate control and restoration of euthyroidism are central when thyrotoxicosis is complicated by atrial fibrillation. ^[18]D5 β-blockade can be useful in thyroid storm and selected tachyarrhythmias, but its use in critical illness remains context-dependent and controversial; excessive or poorly tolerated adrenergic blockade may compromise cardiovascular stability and organ perfusion. ^[123]D Resuscitative and hemodynamic decisions should therefore account for ventricular function, shock, myocardial injury, and the possibility of rapidly changing physiology. ^[46]D5[123]D

Severe thyrotoxicosis may produce cardiovascular events beyond sinus tachycardia or atrial fibrillation. Thyroid-hormone excess has been associated with adrenergic activation, arrhythmogenic susceptibility, and procoagulant changes, and an autopsy series identified biochemical thyroid-hormone excess in seven of 975 consecutive autopsies among cases of sudden death. ^[121]C Uncontrolled Graves' disease has also been reported with spontaneous coronary artery dissection presenting as ST-elevation myocardial infarction and non-obstructive coronary findings. ^[55]C4 Iatrogenic sympathetic stimulation can be hazardous: rapid systemic absorption of locally injected epinephrine during vaginal surgery precipitated cardiovascular crisis in a patient with previously unrecognized hyperthyroidism. ^[57]C4

Thyrotoxicosis-directed therapy and definitive control

Management is multimodal and stepwise: stabilize the patient, identify and treat the trigger, reduce thyroid-hormone synthesis and release when appropriate, limit peripheral adrenergic effects, and provide organ support. ^[36]D5[46]D5 Antithyroid drugs remain central, but treatment must be individualized when hepatic injury, agranulocytosis, pregnancy, critical illness, or impending surgery limits standard options. ^[124]C

Therapeutic plasma exchange (TPE) is a second-line or temporizing intervention for severe hyperthyroidism when antithyroid drugs are contraindicated, ineffective, or insufficient, particularly when thyroidectomy is required. ^[124]C In a five-patient case series involving antithyroid-drug agranulocytosis, cholestatic hepatitis, refractory hyperthyroidism with a large goiter, and thyroid storm during pregnancy, quantifiable free T4 decreased by a mean of 39.0% per session; four patients subsequently underwent successful thyroidectomy. ^[124]C A separate six-case series used TPE as a bridge to thyroidectomy and proposed a preoperative thyroid-hormone target, although the abstract does not report a universal target value or comparative efficacy estimate. ^[60]C4

Short-term lithium bridging is another investigational strategy during the high-risk interval after antithyroid-drug withdrawal before radioiodine. In a retrospective cohort of severe Graves' disease, lithium was administered from antithyroid-drug cessation until 7 days after radioiodine, with a serum target of 0.6–1.0 mmol/L; outcomes were compared with routine management without lithium in 46 versus 100 patients. ^[76]B2b Because this was a single-center retrospective study, lithium bridging should be considered evidence-limited and specialist-supervised rather than routine emergency therapy. ^[76]B2b

Special populations and prevention

Pregnancy requires simultaneous control of maternal thyrotoxicosis and minimization of fetal drug exposure. ^[122]D Untreated or inadequately treated overt hyperthyroidism is associated with preeclampsia, thyroid storm, fetal growth restriction, and fetal or neonatal thyrotoxicosis; differentiation among gestational transient thyrotoxicosis, Graves' disease, and toxic nodular disease requires clinical assessment, trimester-specific thyroid-function thresholds, and thyroid-stimulating immunoglobulin testing when autoimmune disease is suspected. ^[122]D

Immune-checkpoint-inhibitor-associated thyroid dysfunction may progress from biochemical abnormalities or thyroiditis to thyroid storm; combination regimens may increase toxicity and shorten time to onset. ^[25]D5 Such patients require assessment for immune-mediated thyroid disease and other concurrent immune-related endocrinopathies. ^[25]D5 In hospitalized hyperthyroidism, national inpatient data indicate that men represented a minority of admissions but had greater comorbidity burden and reported differences in atrial-fibrillation and outcome profiles compared with women; sex-specific risk assessment may therefore be clinically relevant. ^[127]D

Prognosis and follow-up

A 2026 retrospective cohort developed and internally bootstrapped a prognostic risk score for 30-day all-cause mortality in thyroid storm using multivariable clinical and biochemical predictors. ^[68]B2b The score is potentially useful for risk stratification, but external validation is required before it replaces bedside assessment. ^[68]B2b After stabilization, definitive therapy and adherence planning are essential because poorly controlled disease and abrupt antithyroid-drug discontinuation are recognized precipitants of recurrent crisis. ^[36]D5

Once the acute hypermetabolic state is controlled and the patient is hemodynamically stable, the clinician must select a definitive long-term strategy to prevent recurrence of thyroid storm and maintain sustained euthyroidism. The choice among continued antithyroid drugs (ATDs), radioactive iodine (RAI) ablation, thyroidectomy , and emerging therapies such as radiofrequency ablation ( RFA ) is guided by the underlying etiology, patient preference, comorbidities, and access to high-volume surgical centers ^{[5]D5[20]D5[40]D5}.

Step 1: Selecting the Long-term Strategy

For Graves' disease, the most common cause of thyroid storm, long-term ATD therapy (12-18 months initially) remains first-line in many regions, but recurrence after discontinuation occurs in approximately 50% of patients ^[20]D5. The ATA 2016 guideline (referenced in ^[5]D5) and the JTA 2016 guideline (referenced in ^[5]D5) both recommend definitive therapy with RAI or surgery for patients who fail ATD, have contraindications, or develop thyroid storm. The JTA nationwide survey found that 78% of patients with thyroid storm received methimazole (MMI) during the acute phase, but definitive therapy was pursued in most survivors ^[5]D5.

Step 2: Antithyroid Drugs as Long-term Therapy

For patients who prefer medical management or are poor surgical candidates, long-term ATD therapy (e.g., MMI 5-15 mg daily) is feasible and associated with fewer recurrences when continued for 5-10 years (15% recurrence vs. 50% after 12-18 months) ^[20]D5. The JTA guidelines recommend MMI as the first-choice ATD for compensated Graves' disease, citing a randomized prospective study showing MMI 30 mg/day normalized thyroid hormones more rapidly than PTU 300 mg/day, with a lower incidence of adverse effects ^[5]D5. For patients with thyroid storm, both MMI and PTU are acceptable; the nationwide survey found no significant difference in mortality or severity between the two ^[5]D5. PTU may be preferred when elevated T3 is the dominant feature due to its inhibition of type I deiodinase at doses ≥400 mg/day ^[5]D5.

Step 3: Radioactive Iodine Ablation

RAI is a definitive therapy for Graves' disease and toxic nodular goiter. It is contraindicated in pregnancy and lactation, and in patients with moderate-to-severe Graves' ophthalmopathy ^[20]D5. Before RAI in patients with a history of thyroid storm, achieving euthyroidism with ATDs is recommended to minimize the risk of radiation-induced thyroiditis and storm recurrence. A retrospective cohort study found that lithium carbonate bridging (target serum 0.6-1.0 mmol/L) from ATD withdrawal until 7 days post-RAI was associated with a higher euthyroidism rate at 6 months (30.4% vs. 13.0%, P = 0.009) and a lower hypothyroidism rate (54.3% vs. 77.0%, P = 0.005) compared to standard care, with no cases of thyroid storm in the lithium group vs. 3.0% in controls ^[76]B2b. The same study reported that pre-RAI FT3 was a key modifiable risk factor for treatment failure (adjusted OR 1.55 per 5 pmol/L increase, 95% CI 1.15-2.09, P = 0.004) ^[76]B2b.

Step 4: Thyroidectomy, Timing and Safety

Total thyroidectomy provides rapid and definitive control of hyperthyroidism. The 2016 ATA guidelines recommended that patients be euthyroid before surgery, but this recommendation was based on low-quality evidence ^[64]B2b. A retrospective cohort study of 275 patients (51.3% uncontrolled at surgery) found that uncontrolled patients had higher rates of temporary hypocalcemia (13.4% vs. 4.7%, P = 0.013) and longer operative times, but no patient in either group developed thyroid storm ^[64]B2b. A separate study of 242 patients (23.1% hyperthyroid at surgery) reported that hyperthyroid patients had higher intraoperative heart rates and greater need for antihypertensives, but no difference in adverse outcomes ^[73]B2b. These data suggest that thyroidectomy can be performed safely in actively thyrotoxic patients when high-volume endocrine surgeons are available, without requiring biochemical euthyroidism ^{[64]B2b[73]B2b}.

Step 5: Emerging and Bridging Therapies

Radiofrequency Ablation (RFA): In a prospective study of 30 patients with relapsed Graves' disease and small thyroid glands (median volume 23 mL), single-session RFA achieved disease remission in 60.0% at 12 months and 56.7% at 24 months ^[74]C4. Total thyroid volume <20 mL was associated with 100% remission (vs. 35% for ≥20 mL, P = 0.007), and no case of thyroid storm occurred ^[74]C4. RFA may be considered for selected patients who decline surgery or RAI.

Iopanoic Acid (IOPA): For patients with refractory thyrotoxicosis, IOPA (an oral iodinated contrast agent) can rapidly lower FT3 levels (mean 55% decrease, SEM 4.5%) without significant changes in FT4, allowing safe transition to thyroidectomy ^[72]C4. In a case series of 12 patients, 11 proceeded to uneventful surgery with no attributable side effects ^[72]C4.

Therapeutic Plasma Exchange (TPE): In patients with severe thyrotoxicosis or thyroid storm refractory to medical therapy, TPE can be used as a bridge to thyroidectomy. A case series reported a mean FT4 reduction of 51.7% (95% CI 1.1-4.5 ng/dL) after 5.5 treatments, with a preoperative FT4 goal of 2.5-3.3 ng/dL proposed ^[60]C4.

Step 6: Treat-to-Target Monitoring

After definitive therapy, the goal is sustained euthyroidism. For RAI, thyroid function tests (TSH, FT4, FT3) should be monitored every 4-6 weeks until stable, then annually. For thyroidectomy, levothyroxine replacement is initiated postoperatively, with dose titration to a target TSH 0.5-2.5 mIU/L. For ATD therapy, the dose is adjusted to maintain TSH in the normal range while minimizing adverse effects. The JTA guidelines emphasize that serum FT3 may be disproportionately low in severe illness, so FT4 and TSH should guide therapy ^[5]D5.

Controversies and Guideline Disagreement

Pearl: For patients with a history of thyroid storm, definitive therapy (thyroidectomy or RAI) should be strongly considered once the acute crisis resolves; if surgery is chosen, delaying the procedure for euthyroidism is not mandatory in experienced hands, and lithium or iopanoic acid bridging can optimize outcomes before RAI or surgery.

The long-term management of hyperthyroidism, whether by medication, radioiodine, or surgery, was forged through decades of experience with the acute crisis of thyroid storm. Before the introduction of specific antithyroid therapy, mortality approached 100% in frank thyroid storm. The modern era of treatment began in the 1940s with the thionamides, which block thyroid peroxidase and inhibit hormone synthesis. Propylthiouracil and methimazole remain the backbone of acute therapy, though their history is marked by rare but serious adverse effects: methimazole can cause agranulocytosis and, as documented in case reports, parotitis, a phenomenon that resolves with dose reduction ^[56]C4.

Beta-Blockade and the Advent of Multimodal Therapy

In the 1960s, the recognition that many manifestations of thyrotoxicosis are mediated by adrenergic overactivity led to the introduction of beta-blockers. Propranolol, in particular, became standard both for symptom control and for its ability to inhibit peripheral T4-to-T3 conversion. The landmark addition of iodine (Lugol's solution, introduced as early as the 1920s but now reserved for post-thionamide administration) exploits the Wolff-Chaikoff effect to acutely block hormone release. Glucocorticoids were added in the 1970s to reduce peripheral T4 conversion and to treat relative adrenal insufficiency. However, contemporary evidence questions the routine use of glucocorticoids: studies have found that routine use does not improve survival in thyroid storm patients, suggesting that clinicians should individualize therapy, weighing the risk of infection and hyperglycemia ^[82]C4.

The Paradigm Shift in Surgical Timing

For decades, guidelines mandated that patients be rendered euthyroid before thyroidectomy , based on the fear that surgery would precipitate storm. The 2016 American Thyroid Association guidelines reinforced this recommendation, albeit on low-quality evidence. A landmark retrospective cohort study of 275 patients, the largest to date, directly challenged this dogma: uncontrolled hyperthyroid patients (51.3% of the cohort) underwent thyroidectomy with no cases of perioperative thyroid storm, and complication rates were similar to controlled patients except for a higher rate of temporary hypocalcemia (13.4% vs. 4.7%, p = 0.013) ^[64]B2b. This evidence has shifted practice toward earlier, safer surgical intervention in actively thyrotoxic patients.

Rescue Therapies: Plasmapheresis and ECMO

When medical therapy fails, plasma exchange rapidly removes circulating thyroid hormone. In a case of exogenous thyroid storm from compounded thyroid extract, plasmapheresis for two consecutive days resulted in dramatic clinical improvement and normalization of thyroid function ^[45]C4. For patients with refractory cardiogenic shock or respiratory failure, extracorporeal membrane oxygenation (ECMO) has emerged as a life-saving bridge. In case series, ECMO survival in thyroid storm is reported at 85.2% ^[49]C4. Both venoarterial (VA) and venovenous (VV) ECMO have been used successfully; the choice depends on the predominant organ failure. A recent report describes thyroidectomy performed under general anesthesia while on VV ECMO support, demonstrating that even complex surgical rescue is feasible with appropriate anesthetic management ^[49]C4.

Emerging Definitive Treatment: Radiofrequency Ablation

Radiofrequency ablation ( RFA ) of the thyroid gland is a novel, minimally invasive definitive treatment for persistent or relapsed Graves' disease. In a prospective study of 30 selected patients, single-session RFA achieved disease remission (euthyroid or hypothyroid without antithyroid drugs) in 56.7% at 24 months, with no vocal cord palsy, skin burn, hematoma, or thyroid storm ^[74]C4. Smaller total thyroid volume (<20 mL) was a favorable predictor, with 100% remission in that subgroup ^[74]C4. A pilot study confirmed similar safety and efficacy, with remission rates of 79% at 6 months and 73.3% at 12 months ^[77]C4. RFA offers an alternative to surgery or radioiodine for patients who decline or cannot undergo conventional definitive therapy.

Pearl: The evolution of thyroid storm treatment has been a shift from a single-agent approach to a coordinated, multi-drug, multi-modality strategy, and the most recent evidence now permits safe thyroidectomy even in uncontrolled hyperthyroidism, overturning a decades-old contraindication ^[64]B2b.

Controversies and Guideline Disagreement

The preceding section documented the evolution of treatment from antithyroid drugs to multimodal ICU care. Yet thyroid storm does not occur in an endocrine vacuum - it can herald underlying multiglandular disease or perturb adjacent endocrine axes, requiring syndromic screening and cross-axis surveillance.

Genetic Syndromes and Pituitary Causes

Rare causes of hyperthyroidism that can precipitate storm include TSH-secreting pituitary adenoma s (TSHomas). In a cohort of 12 patients with TSHomas, the mean diagnostic delay was 42.5 months, and longer delay correlated with larger tumors (17.9±3.6 mm vs 9.8±1.0 mm; p=0.004) ^[9]C4. No patient in that series experienced thyroid storm, but the hyperthyroidism can be severe. The key biochemical clue: inappropriately normal or elevated TSH in the presence of elevated free T3 and T4. Refer endocrinology before thyroid ablation - surgery is first-line for TSHomas ^[9]C4. Other genetic syndromes (e.g., McCune-Albright syndrome, familial non-autoimmune hyperthyroidism) are theoretical triggers but lack published storm series.

Co-Axis Effects: Diabetes and Pancreas

Thyroid storm frequently co-occurs with diabetic ketoacidosis (DKA). A case of simultaneous DKA and storm in a 20-year-old male with T1DM and hyperthyroidism illustrates the diagnostic challenge: overlapping symptoms of hyperglycemia, vomiting, and altered mental status ^[86]C4. Conversely, methimazole therapy can induce insulin autoimmune syndrome (IAS) with hypoglycemic coma; one patient developed thyroid storm during IAS treatment ^[89]C4. Clinicians should check glucose, ketones, and insulin autoantibodies in storm patients with unexplained hypoglycemia or hyperglycemia.

Cardiovascular Axis: Takotsubo and ACS

Thyrotoxicosis is a recognized trigger of Takotsubo cardiomyopathy (stress-induced cardiomyopathy). In a case series, 12 cases of Takotsubo associated with thyrotoxicosis were reported, with one presenting as thyroid storm ^[50]C4. Chronic high-altitude hypoxia may further potentiate sympathetic activity and catecholamine responsiveness, as seen in a case of Takotsubo with apical thrombosis ^[22]C4. Additionally, acute coronary syndrome (ACS) can be precipitated by thyrotoxicosis: in 35 cases, 60% presented with STEMI, and thyroid storm was associated with malignant ventricular arrhythmias or sudden cardiac death in ~20% ^[38]B2a. Obtain ECG, troponin, and echocardiography in all storm patients with chest pain or dyspnea.

Immune Activation and Other Axes

Thyroid storm is associated with a marked inflammatory response. A case of storm with multiple organ failure and DIC showed a markedly elevated soluble interleukin-2 receptor level (7,416 U/mL, reference range 135-483), reflecting generalized immune activation ^[92]C4. COVID-19 infection can trigger storm, with cases of thyrotoxic crisis requiring ICU ^[43]C4[85]C4. This suggests that any severe infection in a patient with underlying hyperthyroidism can precipitate storm and cause multi-organ dysfunction.

Syndromic Screening

When thyroid storm is refractory or recurrent, consider screening for underlying genetic syndromes. Unexplained hypercalcemia , pituitary tumor, or family history of endocrine tumors should prompt evaluation for MEN1 . Café-au-lait spots or fibrous dysplasia suggest McCune-Albright syndrome . However, evidence for routine screening is limited; clinical judgment is required.

Pearl: In any patient with thyroid storm and a non-suppressed TSH, suspect a TSH-secreting pituitary adenoma and obtain pituitary imaging before considering thyroid ablation.

The preceding section detailed the genetic and syndromic contexts of hyperthyroidism; once thyroid storm has declared itself, multisystem organ damage determines both short- and long-term outcomes. In-hospital mortality remains substantial, ranging from 5.5% at 30 days in a prospective Japanese registry ^[33]B2b to 10.7-11% in earlier nationwide surveys ^[5]D5[4]C4, and up to 25% in retrospective series ^[36]D5. The 12-fold higher mortality compared with thyrotoxicosis without storm (1.2-3.6% vs 0.1-0.4%) underscores the urgency of aggressive intervention ^[32]B2b.

Acute Complications

Multiple organ failure (MOF) is the most common cause of death, followed by congestive heart failure, respiratory failure, arrhythmia, disseminated intravascular coagulation, gastrointestinal perforation, hypoxic brain syndrome, and sepsis ^[5]D5[4]C4. Among survivors, prolonged ICU stays and ventilator dependence are frequent ^[1]B2b.

Cardiovascular. Atrial fibrillation is the most common cardiovascular manifestation of thyrotoxicosis and may persist after euthyroidism is restored ^[18]D5. Takotsubo (stress-induced) cardiomyopathy can present as the initial manifestation of thyroid storm, mimicking acute coronary syndrome ^[50]C4. Lower left ventricular ejection fraction and shock at presentation are independently associated with 30-day mortality ^[33]B2b.

Respiratory and Neurologic. Respiratory failure necessitating mechanical ventilation occurred in a significant proportion of storm patients ^[1]B2b. Central nervous system dysfunction, including agitation, confusion, delirium, and seizures, is a hallmark of storm and, when present, should prompt immediate escalation of therapy ^[1]B2b[28]C4. Hypoxic brain injury is a recognized long-term sequela ^[4]C4.

Hepatic, GI, and Hematologic. Jaundice (serum bilirubin >3 mg/dL) is a criterion for storm diagnosis and reflects hepatic congestion and dysfunction ^[4]C4. DIC, GI perforation, and sepsis contribute to late mortality ^[4]C4.

Long-term Sequelae

Survivors of thyroid storm carry an increased long-term mortality risk, likely driven by persistent cardiovascular damage and complications of underlying hyperthyroidism ^[20]D5. Delayed diagnosis (median time to diagnosis 5 days) is associated with greater need for intensive care and organ support, emphasizing the importance of early recognition ^[67]B2b.

Prevention and Surveillance

Adherence to the 2016 Japanese Thyroid Association guidelines reduced 30-day mortality when followed (4.7% vs 50% in patients with APACHE II ≥12 when guidelines were not followed) ^[33]B2b. Prompt administration of potassium iodide within 2 days of admission was associated with lower in-hospital mortality in patients with Graves’ disease (OR 0.46, 95% CI 0.25-0.88) ^[63]B2b.

Pearl: The most common cause of death in thyroid storm is multiple organ failure, not arrhythmia, so the clinician must focus on rapid normalization of thyroid hormone levels and comprehensive organ support, not just rate control.

The high mortality of thyroid storm, 11% in the Japanese nationwide survey and 17% in ICU cohorts, underscores the urgency of prevention through early detection and definitive treatment of hyperthyroidism ^[4]C4[12]B2b. Without prompt recognition and aggressive therapy, the natural history is rapid decompensation: multiple organ failure, cardiogenic shock , and death within days. With modern management , outcomes have improved but remain sobering.

Prognosis and Predictors of Mortality

The prospective multicenter registry from Japan reported a 30-day mortality of 5.5%, approximately half the 10.7% rate from the earlier nationwide survey, despite higher disease severity (median APACHE II score 13 vs 10) ^[33]B2b. Adherence to the 2016 Japanese guidelines was associated with significantly lower mortality: among patients with APACHE II ≥12, mortality was 4.7% when guidelines were followed versus 50% when they were not ^[33]B2b. In the French ICU cohort, in-ICU mortality was 17% and 6-month mortality 22%; independent predictors were early cardiogenic shock (OR 9.43, 95% CI 1.77-50.12) and higher SOFA score ^[12]B2b. Coma complicating thyroid storm carries a 38% overall mortality, though this fell from 70% (1935-1977) to 11% (1978-2019) with modern intensive care ^[102]D5.

Natural History Under Treatment

With timely administration of antithyroid drugs (methimazole), potassium iodide, β-blockers, and corticosteroids, thyroid hormone levels begin to fall within 24-48 hours, and clinical improvement typically follows over 3-7 days ^[2]D5[33]B2b. The Japanese registry found that timely administration of methimazole and potassium iodide was linked to lower fatality rates ^[2]D5. However, even with optimal therapy, 38% of ICU patients developed cardiogenic shock within 48 hours, and 22% died within 6 months ^[12]B2b. For patients who survive the acute episode, definitive treatment of the underlying hyperthyroidism (radioiodine, thyroidectomy , or long-term ATD) is essential to prevent recurrence.

Prevention Strategies

Early diagnosis and treatment of hyperthyroidism is the cornerstone. Graves' disease, the most common cause, recurs in approximately 50% of patients after a 12-18 month course of ATD; long-term ATD (5-10 years) reduces recurrence to 15% ^[20]D5. Definitive therapy with radioiodine or thyroidectomy eliminates the risk of storm from the underlying disease. Radiofrequency ablation is emerging as a safe alternative for selected patients with relapsed Graves' disease, achieving 56.7% remission at 24 months ^[74]C4.

Preoperative optimization is mandatory. Elective surgery should be postponed until the patient is euthyroid ^[93]B2a. For urgent surgery or ATD intolerance, second-line pharmacotherapy (corticosteroids, Lugol's iodine, cholestyramine, lithium) and/or therapeutic plasma exchange (TPE) effectively reduce thyroid hormone levels; in a systematic review, no perioperative thyroid storm occurred despite incomplete normalization of hormones ^[93]B2a.

Avoidance of triggers includes prompt treatment of infection, avoidance of iodine-containing agents ( amiodarone , contrast) in susceptible patients, and ensuring medication adherence. Immune checkpoint inhibitors can precipitate thyroid storm; baseline and periodic thyroid function monitoring is recommended during therapy ^[98]D5. COVID-19 infection has been reported to trigger both new-onset Graves' disease and thyroid storm; clinicians should maintain a low threshold for thyroid testing in hyperthyroid patients with SARS-CoV-2 ^[43]C4[99]C4.

Screening for hyperthyroidism in asymptomatic populations is not routinely recommended. In pregnancy, universal screening increases diagnosis and treatment of hypothyroidism but does not clearly improve maternal or infant outcomes ^[65]A1a. For first-degree relatives of patients with Graves' disease, measurement of TSH and TPO antibodies may identify subclinical disease, though evidence for improved outcomes is lacking ^[20]D5.

Pearl: The single most effective prevention is achieving and maintaining euthyroidism in all patients with hyperthyroidism, whether by ATD, radioiodine, or surgery, before the cascade of organ failure begins.

While prognosis and prevention strategies apply broadly, several populations require tailored approaches due to physiologic differences that alter presentation, diagnosis, and management .

Pediatrics

Thyroid storm in children, though rare, presents distinct challenges. In a systematic review of 45 pediatric cases (mean age 11.25 years), the most common features were sinus tachycardia (86.7%) and fever (64%), followed by altered mental status (46%) and diarrhea (31%) ^[41]C4. Graves' disease was the most common etiology, and infection the most frequent trigger ^[41]C4. Seizures occur in approximately 19% of pediatric thyroid storm cases, substantially higher than the 4% in adults, with infants and children affected more often than adolescents ^[16]C4. Importantly, seizures do not necessarily predict poor prognosis; 15 of 16 patients with seizures recovered without persistent neurological complications ^[16]C4. However, the Burch-Wartofsky Point Scale may overestimate severity in children because it assigns 30 points for seizures, and a child's higher baseline heart rate inflates the score ^[16]C4. No pediatric-specific diagnostic criteria exist; management follows adult protocols with weight-based dosing of antithyroid drugs, beta-blockers, and corticosteroids. One case series reported a death in a 13-year-old girl presenting with loss of consciousness and shock ^[109]C4, emphasizing the need for prompt ICU care.

Pregnancy

Pregnancy complicates the diagnosis and management of thyroid storm. The hyperdynamic state can mask thyrotoxicosis, and thyroid storm in pregnancy carries a higher rate of heart failure ^[104]D5. When superimposed on gestational hypertension , diagnosis is particularly challenging due to overlapping symptoms ^[107]C4. A unique cause is hCG-mediated hyperthyroidism from gestational trophoblastic disease, including partial hydatidiform mole ^[106]C4 and choriocarcinoma ^[105]C4; thyroid function normalizes after treatment of the trophoblastic tissue ^{[106]C4[105]C4}.

Universal screening for thyroid dysfunction in pregnancy increases diagnosis of hyperthyroidism (RR 4.50, 95% CI 0.97 to 20.82) but does not clearly improve maternal or infant outcomes ^[65]A1a; case finding based on risk factors remains standard. Management of thyroid storm in pregnancy uses antithyroid drugs (propylthiouracil preferred in first trimester, methimazole thereafter), beta-blockers, and corticosteroids. If medical therapy fails, thyroidectomy can be performed safely even before euthyroidism is achieved, with no increase in thyroid storm risk ^[64]B2b. For refractory cases, therapeutic plasma exchange or iopanoic acid may be used ^{[93]B2a[72]C4}. Delivery planning requires a multidisciplinary team; emergency caesarean section may be necessary ^[107]C4. Antithyroid medications are compatible with breastfeeding .

Elderly

Older adults often present with "apathetic" thyrotoxicosis, lethargy, weakness, and depression rather than hyperadrenergic features, delaying diagnosis. Comorbidities such as atrial fibrillation and heart failure are common and may be exacerbated. Beta-blockers should be started at lower doses (e.g., propranolol 10-20 mg every 6 hours) and titrated cautiously. Antithyroid drug dosing is similar to younger adults but requires close monitoring for adverse effects.

Immunocompromised

Immunocompromised patients are at increased risk for infections, a common thyroid storm trigger. Atypical presentations may occur due to blunted inflammatory responses. Management follows standard protocols with emphasis on infection source control and review of drug interactions.

Pearl: In pediatric thyroid storm, seizures are common and do not necessarily portend poor outcome, but the Burch-Wartofsky scale may overestimate severity; in pregnancy, consider hCG-mediated hyperthyroidism from gestational trophoblastic disease as a reversible cause.